Cochrane Review Group

Vascular

115 systematic reviews in Vascular ask 1,558 questions. 22.2% have no studies to answer them, 18% rest on very low certainty evidence and 23.4% reach moderate or high certainty.

Reviews

115

Questions

1,558

current versions

No studies

22.2%

Moderate or high

23.4%

No studies 346 · 22.2%Ungraded 90 · 5.8%Very low 281 · 18%Low 477 · 30.6%Moderate 313 · 20.1%High 51 · 3.3%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Search questions in Vascular

Thinnest evidence

All no studies and very low questions

Question	Effect	Evidence	Status / GRADE
Intervention NR Failure of hemostatic intervention ( · vascular surgery patients who undergo creation of an anastomosis The role of sealants for achieving anastomotic hemostasis in vascular surgery (2024) · Cochrane	RR 0.46 [0.35, 0.61]	17 studies · 2120 participants	Very low
Intervention NR Death from bleeding complications (up to 30 days · vascular surgery patients who undergo creation of an anastomosis The role of sealants for achieving anastomotic hemostasis in vascular surgery (2024) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Change in claudication distance from baseline (m) · people with intermittent claudication Mobile health technologies to improve walking distance in people with intermittent claudication (2024) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Amputation‐free survival · people with intermittent claudication Mobile health technologies to improve walking distance in people with intermittent claudication (2024) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Revascularisation‐free survival · people with intermittent claudication Mobile health technologies to improve walking distance in people with intermittent claudication (2024) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Major adverse limb events (MALE) · people with intermittent claudication Mobile health technologies to improve walking distance in people with intermittent claudication (2024) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Above‐ankle amputation · people with intermittent claudication Mobile health technologies to improve walking distance in people with intermittent claudication (2024) · Cochrane	no estimate extracted	NR	No studies
Supervised exercise therapy following vascular intervention vs vascular intervention alone MWD ‐ change from baseline · people with symptomatic peripheral arterial disease§ Effects of additional exercise therapy after a successful vascular intervention for people with symptomatic… (2024) · Cochrane	no estimate extracted	2 studies · 89 participants	Very low
Supervised exercise therapy following vascular intervention vs vascular intervention alone 6MWT ‐ change from baseline · people with symptomatic peripheral arterial disease§ Effects of additional exercise therapy after a successful vascular intervention for people with symptomatic… (2024) · Cochrane	no estimate extracted	1 study · 49 participants	Very low
Supervised exercise therapy following vascular intervention vs vascular intervention alone PFWD ‐ change from baseline · people with symptomatic peripheral arterial disease§ Effects of additional exercise therapy after a successful vascular intervention for people with symptomatic… (2024) · Cochrane	no estimate extracted	2 studies · 87 participants	Very low
Supervised exercise therapy following vascular intervention vs vascular intervention alone ABI ‐ absolute value · people with symptomatic peripheral arterial disease§ Effects of additional exercise therapy after a successful vascular intervention for people with symptomatic… (2024) · Cochrane	no estimate extracted	2 studies · 110 participants	Very low
Supervised exercise therapy following vascular intervention vs vascular intervention alone Mortality · people with symptomatic peripheral arterial disease§ Effects of additional exercise therapy after a successful vascular intervention for people with symptomatic… (2024) · Cochrane	OR 0.92 [0.42, 2]	6 studies · 346 participants	Very low

Reviews 115

The role of sealants for achieving anastomotic hemostasis in vascular surgery

Ma, G-W, Kucey, A, et al. · Cochrane Database of Systematic Reviews · 2024

Vascular

Thinnest evidence

Reviews 115

The role of sealants for achieving anastomotic hemostasis in vascular surgery

Mobile health technologies to improve walking distance in people with intermittent claudication

Effects of additional exercise therapy after a successful vascular intervention for people with symptomatic peripheral arterial disease

Remote ischaemic preconditioning versus no remote ischaemic preconditioning for vascular and endovascular surgical procedures

Totally percutaneous versus surgical cut‐down femoral artery access for elective bifurcated abdominal endovascular aneurysm repair

Physical exercise for the treatment of non‐ulcerated chronic venous insufficiency

Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis

Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism

Balneotherapy for chronic venous insufficiency

Drugs to reduce bleeding and transfusion in major open vascular or endovascular surgery: a systematic review and network meta‐analysis

Interventions for motor rehabilitation in people with transtibial amputation due to peripheral arterial disease or diabetes

Duplex ultrasound for surveillance of lower limb revascularisation

Intravenous immunoglobulin for the treatment of Kawasaki disease

Prophylactic anticoagulants for non‐hospitalised people with COVID‐19

Tourniquet use for people with peripheral arterial disease undergoing major lower limb amputations

Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism

Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy

Local intramuscular transplantation of autologous bone marrow mononuclear cells for critical lower limb ischaemia

Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults

Outpatient versus inpatient treatment for acute pulmonary embolism

Corticosteroids for the treatment of Kawasaki disease in children

Antiplatelet agents for the treatment of deep venous thrombosis

Catheter‐directed therapies for the treatment of high risk (massive) and intermediate risk (submassive) acute pulmonary embolism

Interventions for the long‐term prevention of hereditary angioedema attacks

Ultrasound guidance versus landmark method for peripheral venous cannulation in adults